FR4619M - - Google Patents

Info

Publication number
FR4619M
FR4619M FR3974A FR3974A FR4619M FR 4619 M FR4619 M FR 4619M FR 3974 A FR3974 A FR 3974A FR 3974 A FR3974 A FR 3974A FR 4619 M FR4619 M FR 4619M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR3974A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR3974A priority Critical patent/FR4619M/fr
Application granted granted Critical
Publication of FR4619M publication Critical patent/FR4619M/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR3974A 1965-02-01 1965-02-01 Expired FR4619M (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR3974A FR4619M (de) 1965-02-01 1965-02-01

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR3974A FR4619M (de) 1965-02-01 1965-02-01

Publications (1)

Publication Number Publication Date
FR4619M true FR4619M (de) 1966-11-28

Family

ID=8569689

Family Applications (1)

Application Number Title Priority Date Filing Date
FR3974A Expired FR4619M (de) 1965-02-01 1965-02-01

Country Status (1)

Country Link
FR (1) FR4619M (de)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080229A1 (de) * 1981-11-20 1983-06-01 Pietro Isnardi & C. Spa Salicylderivate von N-Acetyl-Cystein
FR2523127A1 (fr) * 1982-03-11 1983-09-16 Elmu Sa N,s-diacetylcysteine utile notamment comme agent mucolytique, son procede de fabrication et compositions pharmaceutiques la contenant
EP0301474A2 (de) * 1987-07-30 1989-02-01 Magis Farmaceutici S.P.A. Cystein-Derivate mit Expectorans-Wirkung
EP0499882A1 (de) * 1991-02-21 1992-08-26 ZAMBON GROUP S.p.A. N-acetyl-cysteine Derivate enthaltende pharmazeutische Zusammensetzung zur Behandlung von Katarakt
WO1995003792A1 (de) * 1993-07-29 1995-02-09 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Verwendung von thiolverbindungen zur therapie von viralen erkrankungen
WO2003053424A1 (en) * 2001-12-11 2003-07-03 2458781 Canada Inc. Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080229A1 (de) * 1981-11-20 1983-06-01 Pietro Isnardi & C. Spa Salicylderivate von N-Acetyl-Cystein
FR2523127A1 (fr) * 1982-03-11 1983-09-16 Elmu Sa N,s-diacetylcysteine utile notamment comme agent mucolytique, son procede de fabrication et compositions pharmaceutiques la contenant
EP0301474A2 (de) * 1987-07-30 1989-02-01 Magis Farmaceutici S.P.A. Cystein-Derivate mit Expectorans-Wirkung
EP0301474A3 (en) * 1987-07-30 1989-10-04 Magis Farmaceutici S.P.A. New cysteine derivatives having expectorant activity
EP0499882A1 (de) * 1991-02-21 1992-08-26 ZAMBON GROUP S.p.A. N-acetyl-cysteine Derivate enthaltende pharmazeutische Zusammensetzung zur Behandlung von Katarakt
US5519054A (en) * 1991-02-21 1996-05-21 Zambon Group S.P.A. Pharmaceutical compositions containing N-acetyl-cysteine derivatives useful for the treatment of cataract
WO1995003792A1 (de) * 1993-07-29 1995-02-09 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Verwendung von thiolverbindungen zur therapie von viralen erkrankungen
WO2003053424A1 (en) * 2001-12-11 2003-07-03 2458781 Canada Inc. Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production

Similar Documents

Publication Publication Date Title
BE673125A (de)
BE675324A (de)
AU416352B2 (de)
AU6521465A (de)
BE675655A (de)
BE674966A (de)
BE657977A (de)
BE666856A (de)
BE668917A (de)
BE669636A (de)
BE669939A (de)
BE670403A (de)
BE671675A (de)
BE671734A (de)
BE671749A (de)
BE671856A (de)
BE672238A (de)
BE672573A (de)
BE672604A (de)
BE672739A (de)
BE672778A (de)
BE673393A (de)
BE673418A (de)
BE673583A (de)
BE674013A (de)